newsfilter
← Latest News
GlobeNewswire·

Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial

EMERYVILLE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced that it is now